162 filings
Page 3 of 9
6-K
vnv 6pvdw
24 Jan 23
GENFIT Announces 2023 Financial Calendar
4:10pm
6-K
7ixkqotlsjxl7 1q1m
5 Jan 23
GENFIT to Participate in Upcoming Investor Conferences
4:10pm
6-K
5td1qewys6qai8ihh262
17 Nov 22
GENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved Liver Diseases
4:10pm
6-K
qd2 9f1c6xw9ggv3tl
10 Nov 22
GENFIT Reports Third Quarter 2022 Financial Information
4:10pm
6-K
ssax32k k1qvy
25 Oct 22
Current report (foreign)
4:10pm
6-K
fllaggzph503pj
29 Sep 22
GENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Acquisition of Versantis
4:10pm
6-K
1fcisgg
28 Sep 22
GENFITÂ Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm
6-K
tz2rpgrjtdc9
19 Sep 22
GENFIT to Acquire Clinical-stage Biopharmaceutical Company Versantis, expanding its Portfolio in Liver Diseases
6:10am
6-K
frys7jlr756o72 9790
13 Sep 22
FDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of Cholangiocarcinoma
4:15pm
6-K
2zfq0 l555k
8 Jul 22
Current report (foreign)
4:15pm
6-K
31vp7xr2vz7oh
25 May 22
Current report (foreign)
4:10pm
6-K
t6qkl1cy01ws4d49
11 May 22
GENFIT Reports First Quarter 2022 Financial Information
4:10pm
6-K
ezf5yuwqv3 6xz2t2
29 Apr 22
GENFIT Announces Publication of the 2021 Universal
4:10pm
6-K
3hlxdvavh
27 Apr 22
Shareholders' and Unitholders' Meetings
9:43am
6-K
l91v0eb dtz2l2wg
20 Apr 22
Current report (foreign)
4:10pm
6-K
hffzw7iqnypc
7 Apr 22
GENFIT Reports Full-Year 2021 Financial Results and Provides Corporate Update
4:10pm
6-K
1mjzml97ck7
1 Mar 22
Current report (foreign)
6:08am
6-K
gs4849
24 Jan 22
Current report (foreign)
4:10pm
6-K
07b v193bvbw
17 Dec 21
Current report (foreign)
6:05am